Spondylitis

SAA's 5th Annual Global Spondyloarthritis Summit Empowers Patient Community with Access to Health Experts & Information

Retrieved on: 
Thursday, May 4, 2023

ENCINO, Calif., May 3, 2023 /PRNewswire-PRWeb/ -- As an integral component of its mission and ongoing commitment to providing programs to educate and empower the spondyloarthritis (SpA) community, the Spondylitis Association of America (SAA) will host its 5th Annual Global Spondyloarthritis Summit, May 5- 6, 2023. This year's educational program provides attendees access to 12 presentations covering advanced and introductory topics such as treatment options, diet and nutrition, genetics, sleep and spondyloarthritis, gender differences, surgery recommendations, cannabis, cardiovascular disease, flares, and more. Free access to Summit presentations begins at 9 am PDT on Friday, May 5, 2023.

Key Points: 
  • As an integral component of its mission and ongoing commitment to providing programs to educate and empower the spondyloarthritis community, SAA will host its 5th Annual Global Spondyloarthritis Summit, May 5- 6, 2023.
  • ENCINO, Calif., May 3, 2023 /PRNewswire-PRWeb/ -- As an integral component of its mission and ongoing commitment to providing programs to educate and empower the spondyloarthritis (SpA) community, the Spondylitis Association of America (SAA) will host its 5th Annual Global Spondyloarthritis Summit , May 5- 6, 2023.
  • Free access to Summit presentations begins at 9 am PDT on Friday, May 5, 2023.
  • "The Global Spondyloarthritis Summit is just one example of our ongoing commitment to empowering the SpA community, and we are proud to be able to offer access to this content – all at no charge," Shafer added.

Global Psoriatic Arthritis Treatment Market Report 2023: Recent Development of Interleukin-17 Inhibitors Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 18, 2023

It is a heterogeneous disease and is categorized into 5 subtypes, namely, symmetric psoriatic arthritis, asymmetric psoriatic arthritis, distal psoriatic arthritis, spondylitis, and arthritis mutilans.

Key Points: 
  • It is a heterogeneous disease and is categorized into 5 subtypes, namely, symmetric psoriatic arthritis, asymmetric psoriatic arthritis, distal psoriatic arthritis, spondylitis, and arthritis mutilans.
  • The factors driving the psoriatic arthritis treatment market are rising public health awareness regarding skin diseases, early disease diagnosis, and the recent development of interleukin-17 inhibitors.
  • Currently, the drugs prescribed for psoriatic arthritis are based on the severity of the disease such as mild, moderate, or severe psoriatic arthritis.
  • The development of Interleukin-17 inhibitors such as secukinumab, ixekizumab, and brodalumab have better drug safety and efficacy for the treatment of psoriatic arthritis.

Orthopedic Orthotic Devices Global Market Report 2022: Featuring Ossur, Breg, DeRoyal Industries, Truelife & More - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 20, 2022

The "Orthopedic Orthotic Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Orthopedic Orthotic Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030" report has been added to ResearchAndMarkets.com's offering.
  • Additionally, the rising geriatric population with joint deformities and traumatic injuries will result in deep market penetration for orthopedic orthotic devices.
  • The limiting factors related to this market are the ineffective reimbursement policies deter the patients from availing orthotic devices for treatment and maintaining the orthotic devices such as cleaning, oiling, etc.
  • The growth of orthopedic orthotic devices market is determined by rising prevalence of chronic diseases such as osteoporosis, spondylitis and rheumatoid arthritis etc.

Europe Ankylosing Spondylitis Market and Competitive Landscape Report 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 27, 2022

The "Europe Ankylosing Spondylitis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Ankylosing Spondylitis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Europe Ankylosing Spondylitis Market and Competitive Landscape report provides comprehensive insights into Ankylosing Spondylitis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Ankylosing Spondylitis treatment options, Ankylosing Spondylitis late-stage clinical trials pipeline, Ankylosing Spondylitis prevalence by countries, Ankylosing Spondylitis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Ankylosing Spondylitis pipeline: Find out drugs in clinical trials for the treatment of Ankylosing Spondylitis by development phase 3, phase 2, by pharmacological class and company
    Ankylosing Spondylitis drugs: Identify key drugs marketed and prescribed for Ankylosing Spondylitis in the US, including trade name, molecule name, and company
    Ankylosing Spondylitis market valuations: Find out the market size for Ankylosing Spondylitis drugs in 2020 by countries.

Life After Diagnosis, a Video Series by the Spondylitis Association of America (SAA), Receives Two Digital Content Awards

Retrieved on: 
Tuesday, July 12, 2022

ENCINO, Calif., July 12, 2022 /PRNewswire-PRWeb/ -- Life After Diagnosis, SAA's informational 7- part video series for those newly diagnosed with ankylosing spondylitis (AS), has been honored with a MUSE Award for the best educational video and a Vega Award for the best interactive online video.

Key Points: 
  • Presented annually, the Vega Digital Award recognizes the creative genius of digital content creators worldwide.
  • Life After Diagnosis is receiving this year's award for its video segment, Navigating Relationships with AS.
  • In addition, the MUSE Creative Awards honor creative professionals who utilize their talents to create digital content that inspires people to reach their highest potential.
  • The video series was supported by an educational grant provided by Pfizer, with SAA being solely responsible for its content.

Global Ankylosing Spondylitis Market Analysis and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Drug Sales, Forecasts, and Market Shares 2018-2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 29, 2022

The "Global Ankylosing Spondylitis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Ankylosing Spondylitis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • The research provides comprehensive insights into Ankylosing Spondylitis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Ankylosing Spondylitis treatment options, Ankylosing Spondylitis late-stage clinical trials pipeline, Ankylosing Spondylitis prevalence by countries, Ankylosing Spondylitis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Ankylosing Spondylitis pipeline: Find out drugs in clinical trials for the treatment of Ankylosing Spondylitis by development phase 3, phase 2, by pharmacological class and company
    Ankylosing Spondylitis drugs: Identify key drugs marketed and prescribed for Ankylosing Spondylitis in the US, including trade name, molecule name, and company
    Ankylosing Spondylitis market valuations: Find out the market size for Ankylosing Spondylitis drugs in 2020 by countries.

The Spondylitis Association of America Launches Primary Care and Chiropractic Initiative: Accredited Continuing Education Focused on Earlier SpA Diagnosis

Retrieved on: 
Friday, December 3, 2021

During this extensive delay to diagnosis, the disease goes uncontrolled and unchecked by treatment and causes damage damage that cannot be undone.

Key Points: 
  • During this extensive delay to diagnosis, the disease goes uncontrolled and unchecked by treatment and causes damage damage that cannot be undone.
  • SAA is tackling this issue by rolling out accredited continuing education programs to aid primary care and chiropractic professionals in the early recognition of axSpA symptoms.
  • *This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of EXCEL Continuing Education and The Spondylitis Association of America.
  • EXCEL Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.

Endurance Athlete Living with Ankylosing Spondylitis Undertakes 2,855-mile Journey to Benefit Spondylitis Association of America

Retrieved on: 
Monday, June 7, 2021

ENCINO, Calif., June 7, 2021 /PRNewswire-PRWeb/ -- Helgi Olafson, a health activist, professional yacht chef, and endurance athlete living with ankylosing spondylitis, will undertake an epic journey to benefit the Spondylitis Association of America.

Key Points: 
  • ENCINO, Calif., June 7, 2021 /PRNewswire-PRWeb/ -- Helgi Olafson, a health activist, professional yacht chef, and endurance athlete living with ankylosing spondylitis, will undertake an epic journey to benefit the Spondylitis Association of America.
  • Olafson has been living with ankylosing spondylitis, a form of spondyloarthritis, since he was diagnosed at the age of 19.
  • Olafson is asking that donations made in support of his journey be directed to the Spondylitis Association of America.
  • Since our founding in 1983, the Spondylitis Association of America has been the leading national nonprofit providing educational resources, connections, and the critical emotional support that people living with spondylitis need.

Global Ankylosing Spondylitis Market (2021 to 2028) - Share, Size, Trends and Industry Analysis Report - ResearchAndMarkets.com

Retrieved on: 
Friday, May 14, 2021

b'The "Ankylosing Spondylitis Market Share, Size, Trends, Industry Analysis Report, By Drug; By Treatment Type; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global ankylosing spondylitis market size is expected to reach USD 8.45 billion by 2028 according to a new study.

Key Points: 
  • b'The "Ankylosing Spondylitis Market Share, Size, Trends, Industry Analysis Report, By Drug; By Treatment Type; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global ankylosing spondylitis market size is expected to reach USD 8.45 billion by 2028 according to a new study.
  • The report gives a detailed insight into current market dynamics and provides analysis on future market growth.\nAnkylosing Spondylitis (AS), also known as Bechterew disease is the rare type of arthritis causing stiffness and intense pain in the individual\'s spine, starting from lower back sacral bones.
  • Ankylosing spondylitis is started from an individual\'s sacroiliac joints, where the spinal cord connects with the pelvic girdle.
  • According to the recent population estimates the prevalence rate of ankylosing spondylitis in the U.S. is around 0.2-0.5 percent and based on market data from multiple countries the global incidence rate stood at 0.4-14 per 100,000 individuals.\n'

2021 Insights on the Ankylosing Spondylitis Global Market - Identify Target Patient Population - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 13, 2021

b'The "Global Ankylosing Spondylitis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThis report provides Ankylosing Spondylitis epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Ankylosing Spondylitis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThis report provides Ankylosing Spondylitis epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Ankylosing Spondylitis patients, history of the disease at the population level (Ankylosing Spondylitis prevalence, Ankylosing Spondylitis incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Ankylosing Spondylitis patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Ankylosing Spondylitis market sizing, assessing market potential, and developing drug forecast models\nIdentify Ankylosing Spondylitis patients segments through age groups, gender, and disease sub-types\nEvaluate Ankylosing Spondylitis market opportunities, identify target patient population\n'